Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in antiretroviral regimens for virologically suppressed adults with HIV-1 infection: a randomised, active-controlled, multicentre, open-label, phase 3, non-inferiority study.
22 auth. A. Mills, J. Arribas, J. Andrade-Villanueva, G. Diperri, J. van Lunzen, E. Koenig, R. Elion, M. Cavassini, J. Madruga, J. Brunetta, ... D. Shamblaw, E. Dejesus, C. Orkin, D. Wohl, I. Brar, J. Stephens, P. Girard, G. Huhn, Andrew Plummer, Yapei Liu, A. Cheng, S. McCallister